MDxHealth SA's EBIT is $-12M, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of May 31, 2026
Trailing 12 months ending May 31, 2026
As of the most recent data (May 2026), MDXH shows a EBIT of $-12M. That compares with $-24M in the prior-year period — up 49.5% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MDXH's EBIT is now $-12M (was $-24M) — a 49.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MDxHealth SA is outperforming or lagging.
The Healthcare sector average EBIT is about $110B. MDxHealth SA is at $-12M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how MDXH stacks up against individual peers as well.
Tracking MDXH's ebit over time shows whether MDxHealth SA is scaling, shrinking, or reshaping that part of the business. The current reading is $-12M That compares with $-24M in the prior-year period — up 49.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has MDxHealth SA's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-12M) with ownership activity and broader fundamentals.